- Home
- TCRX vs SGA Comparison
TCRX vs SGA Comparison
Compare TCRX & SGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- SGA
- Stock Information
- Founded
- TCRX 2018
- SGA 1986
- Country
- TCRX United States
- SGA United States
- Employees
- TCRX N/A
- SGA N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- SGA Broadcasting
- Sector
- TCRX Health Care
- SGA Consumer Discretionary
- Exchange
- TCRX Nasdaq
- SGA Nasdaq
- Market Cap
- TCRX 90.5M
- SGA 74.2M
- IPO Year
- TCRX 2021
- SGA 1992
- Fundamental
- Price
- TCRX $1.45
- SGA $12.25
- Analyst Decision
- TCRX Strong Buy
- SGA
- Analyst Count
- TCRX 6
- SGA 0
- Target Price
- TCRX $9.50
- SGA N/A
- AVG Volume (30 Days)
- TCRX 774.8K
- SGA 4.1K
- Earning Date
- TCRX 05-06-2025
- SGA 05-08-2025
- Dividend Yield
- TCRX N/A
- SGA 8.16%
- EPS Growth
- TCRX N/A
- SGA N/A
- EPS
- TCRX N/A
- SGA 0.55
- Revenue
- TCRX $4,421,000.00
- SGA $111,837,000.00
- Revenue This Year
- TCRX $68.86
- SGA N/A
- Revenue Next Year
- TCRX $14.01
- SGA $5.04
- P/E Ratio
- TCRX N/A
- SGA $22.43
- Revenue Growth
- TCRX N/A
- SGA N/A
- 52 Week Low
- TCRX $1.02
- SGA $10.75
- 52 Week High
- TCRX $9.29
- SGA $18.19
- Technical
- Relative Strength Index (RSI)
- TCRX 49.42
- SGA 55.44
- Support Level
- TCRX $1.33
- SGA $11.88
- Resistance Level
- TCRX $1.49
- SGA $12.45
- Average True Range (ATR)
- TCRX 0.11
- SGA 0.45
- MACD
- TCRX 0.02
- SGA 0.02
- Stochastic Oscillator
- TCRX 69.12
- SGA 71.43
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About SGA Saga Communications Inc. (FL)
Saga Communications Inc is a broadcast company engaged in acquiring, developing, and operating broadcast properties. The company's objective is to operate top billing radio stations in mid-sized markets. It derives a majority of its revenue from the sale of advertising for broadcast on its stations.